|
US8497246B2
(en)
|
2006-08-18 |
2013-07-30 |
Armagen Technologies, Inc. |
Methods for diagnosing and treating CNS disorders by trans-blood-brain barrier delivery of protein compositions
|
|
JP5901877B2
(ja)
|
2007-07-27 |
2016-04-13 |
アーメイゲン・テクノロジーズ・インコーポレイテッドＡｒｍａｇｅｎ Ｔｅｃｈｎｏｌｏｇｉｅｓ， Ｉｎｃ． |
中枢神経系のα−Ｌ−イデュロニダーゼ活性を増加させるための方法および組成物
|
|
ES2725200T3
(es)
|
2009-10-09 |
2019-09-20 |
Armagen Inc |
Métodos y composiciones para aumentar la actividad de iduronato 2-sulfatasa en el SNC
|
|
JP2015502397A
(ja)
|
2011-12-23 |
2015-01-22 |
ファイザー・インク |
部位特異的コンジュゲーションのための操作された抗体定常領域、ならびにそのための方法および使用
|
|
CA2872908C
(en)
|
2012-05-10 |
2023-11-14 |
Gerhard Frey |
Multi-specific monoclonal antibodies
|
|
WO2014022592A1
(en)
|
2012-08-02 |
2014-02-06 |
Jn Biosciences Llc |
Antibodies or fusion proteins multimerized via cysteine mutation and a mu tailpiece
|
|
JP6851199B2
(ja)
*
|
2014-03-05 |
2021-03-31 |
ユーシービー バイオファルマ エスアールエル |
多量体Ｆｃタンパク質
|
|
TW201619188A
(zh)
*
|
2014-03-05 |
2016-06-01 |
優稀美生物醫藥公司 |
多聚體Ｆｃ蛋白質
|
|
KR102380402B1
(ko)
|
2014-04-03 |
2022-03-31 |
아이쥐엠 바이오사이언스 인코포레이티드 |
변형된 j-사슬
|
|
AU2015266958A1
(en)
|
2014-05-28 |
2016-12-08 |
Agenus Inc. |
Anti-GITR antibodies and methods of use thereof
|
|
MA41044A
(fr)
|
2014-10-08 |
2017-08-15 |
Novartis Ag |
Compositions et procédés d'utilisation pour une réponse immunitaire accrue et traitement contre le cancer
|
|
US11566082B2
(en)
|
2014-11-17 |
2023-01-31 |
Cytiva Bioprocess R&D Ab |
Mutated immunoglobulin-binding polypeptides
|
|
SI3235830T1
(sl)
|
2014-12-19 |
2020-12-31 |
Jiangsu Hengrui Medicine Co., Ltd. |
Proteinski kompleks interlevkina 15 in njegove uporabe
|
|
US10538589B2
(en)
*
|
2015-01-14 |
2020-01-21 |
Armagen Inc. |
Methods and compositions for increasing N-acetylglucosaminidase (NAGLU) activity in the CNS using a fusion antibody comprising an anti-human insulin receptor antibody and NAGLU
|
|
EP3750918A1
(en)
*
|
2015-01-20 |
2020-12-16 |
IGM Biosciences, Inc. |
Tumor necrosis factor (tnf) superfamily receptor binding molecules and uses thereof
|
|
CN115093479A
(zh)
*
|
2015-03-04 |
2022-09-23 |
Igm生物科学股份有限公司 |
Cd20结合分子及其用途
|
|
JP6882184B2
(ja)
*
|
2015-03-25 |
2021-06-02 |
アイジーエム バイオサイエンシズ インコーポレイテッド |
多価ｂ型肝炎ウイルス抗原結合分子およびその使用
|
|
MX2017012805A
(es)
*
|
2015-04-07 |
2018-04-11 |
Genentech Inc |
Complejo de unión a antígenos con actividad agonista y métodos de uso.
|
|
WO2016168758A1
(en)
|
2015-04-17 |
2016-10-20 |
Igm Biosciences, Inc. |
Multi-valent human immunodeficiency virus antigen binding molecules and uses thereof
|
|
PH12017502013B1
(en)
|
2015-05-07 |
2022-07-22 |
Agenus Inc |
Anti-ox40 antibodies and methods of use thereof
|
|
DK3355913T3
(da)
|
2015-09-30 |
2024-12-02 |
Igm Biosciences Inc |
Bindingsmolekyler med modificeret j-kæde
|
|
US11639389B2
(en)
|
2015-09-30 |
2023-05-02 |
Igm Biosciences, Inc. |
Binding molecules with modified J-chain
|
|
EP3368076B1
(en)
|
2015-10-30 |
2025-04-30 |
Galaxy Biotech, LLC |
Highly potent antibodies binding to death receptor 4 and death receptor 5
|
|
TWI726942B
(zh)
|
2015-11-30 |
2021-05-11 |
美商輝瑞股份有限公司 |
位點專一性ｈｅｒ２抗體藥物共軛體
|
|
TWI703160B
(zh)
*
|
2015-11-30 |
2020-09-01 |
美商輝瑞股份有限公司 |
用於部位專一性接合之抗體和抗體片段
|
|
SG10201912984WA
(en)
|
2015-12-02 |
2020-03-30 |
Agenus Inc |
Antibodies and methods of use thereof
|
|
JP7328761B2
(ja)
|
2016-01-11 |
2023-08-17 |
インヒブルクス インコーポレイテッド |
多価多重特異性ｏｘ４０結合融合タンパク質
|
|
CA3016563A1
(en)
|
2016-03-21 |
2017-09-28 |
Elstar Therapeutics, Inc. |
Multispecific and multifunctional molecules and uses thereof
|
|
US10703774B2
(en)
|
2016-09-30 |
2020-07-07 |
Ge Healthcare Bioprocess R&D Ab |
Separation method
|
|
US10513537B2
(en)
|
2016-05-11 |
2019-12-24 |
Ge Healthcare Bioprocess R&D Ab |
Separation matrix
|
|
WO2017194593A1
(en)
|
2016-05-11 |
2017-11-16 |
Ge Healthcare Bioprocess R&D Ab |
Method of cleaning and/or sanitizing a separation matrix
|
|
US10889615B2
(en)
|
2016-05-11 |
2021-01-12 |
Cytiva Bioprocess R&D Ab |
Mutated immunoglobulin-binding polypeptides
|
|
US10730908B2
(en)
|
2016-05-11 |
2020-08-04 |
Ge Healthcare Bioprocess R&D Ab |
Separation method
|
|
JP7031934B2
(ja)
|
2016-05-11 |
2022-03-08 |
サイティバ・バイオプロセス・アールアンドディ・アクチボラグ |
分離マトリックス
|
|
US10654887B2
(en)
|
2016-05-11 |
2020-05-19 |
Ge Healthcare Bio-Process R&D Ab |
Separation matrix
|
|
CN109311949B
(zh)
|
2016-05-11 |
2022-09-16 |
思拓凡生物工艺研发有限公司 |
储存分离基质的方法
|
|
US20190338040A1
(en)
*
|
2016-07-20 |
2019-11-07 |
Igm Biosciences, Inc. |
Multimeric cd137/4-1bb binding molecules and uses thereof
|
|
EP3496536A4
(en)
*
|
2016-07-20 |
2020-02-12 |
IGM Biosciences, Inc. |
MULTIMERE CD40-BINDING MOLECULES AND USES THEREOF
|
|
US12448411B2
(en)
|
2016-09-30 |
2025-10-21 |
Cytiva Bioprocess R&D Ab |
Separation method
|
|
EP3538152A4
(en)
|
2016-11-09 |
2020-09-30 |
Agenus Inc. |
ANTI-OX40 ANTIBODIES, ANTI-GITR ANTIBODIES, AND PROCESSES FOR USE
|
|
US20200291089A1
(en)
|
2017-02-16 |
2020-09-17 |
Elstar Therapeutics, Inc. |
Multifunctional molecules comprising a trimeric ligand and uses thereof
|
|
WO2018222901A1
(en)
|
2017-05-31 |
2018-12-06 |
Elstar Therapeutics, Inc. |
Multispecific molecules that bind to myeloproliferative leukemia (mpl) protein and uses thereof
|
|
JP2020531002A
(ja)
|
2017-08-15 |
2020-11-05 |
キンドレッド バイオサイエンシズ インコーポレイテッド |
獣医学用ｉｇｇ ｆｃ変異体
|
|
WO2019035938A1
(en)
|
2017-08-16 |
2019-02-21 |
Elstar Therapeutics, Inc. |
MULTISPECIFIC MOLECULES BINDING TO BCMA AND USES THEREOF
|
|
US11364303B2
(en)
|
2017-09-29 |
2022-06-21 |
Pfizer Inc. |
Cysteine engineered antibody drug conjugates
|
|
AU2018347607B2
(en)
|
2017-10-14 |
2025-08-21 |
Cytomx Therapeutics, Inc. |
Antibodies, activatable antibodies, bispecific antibodies, and bispecific activatable antibodies and methods of use thereof
|
|
US12247060B2
(en)
|
2018-01-09 |
2025-03-11 |
Marengo Therapeutics, Inc. |
Calreticulin binding constructs and engineered T cells for the treatment of diseases
|
|
WO2019178362A1
(en)
|
2018-03-14 |
2019-09-19 |
Elstar Therapeutics, Inc. |
Multifunctional molecules that bind to calreticulin and uses thereof
|
|
WO2019178364A2
(en)
|
2018-03-14 |
2019-09-19 |
Elstar Therapeutics, Inc. |
Multifunctional molecules and uses thereof
|
|
KR20210009421A
(ko)
|
2018-06-14 |
2021-01-26 |
바이오아트라, 엘엘씨 |
다중 특이적 항체 구조체
|
|
CA3105448A1
(en)
|
2018-07-03 |
2020-01-09 |
Elstar Therapeutics, Inc. |
Anti-tcr antibody molecules and uses thereof
|
|
KR102232659B1
(ko)
*
|
2018-07-16 |
2021-03-26 |
전북대학교 산학협력단 |
항원전달용 폴리펩타이드, 이를 포함하는 Fc-융합 단백질 및 이의 용도
|
|
BR112021002164A2
(pt)
|
2018-08-13 |
2021-08-03 |
Inhibrx, Inc. |
polipeptídeos de ligação a ox40 e usos dos mesmos
|
|
AU2019416344A1
(en)
*
|
2018-12-27 |
2021-07-01 |
Elanco Us Inc. |
IgG Fc variants for veterinary use
|
|
GB2597851B
(en)
|
2019-02-21 |
2024-05-29 |
Marengo Therapeutics Inc |
Antibody molecules that bind to NKP30 and uses thereof
|
|
CN114127112A
(zh)
|
2019-02-21 |
2022-03-01 |
马伦戈治疗公司 |
与t细胞结合的多功能分子及其治疗自身免疫性病症的用途
|
|
EP3927744A1
(en)
|
2019-02-21 |
2021-12-29 |
Marengo Therapeutics, Inc. |
Multifunctional molecules that bind to t cell related cancer cells and uses thereof
|
|
EP3927431A1
(en)
|
2019-02-21 |
2021-12-29 |
Marengo Therapeutics, Inc. |
Anti-tcr antibody molecules and uses thereof
|
|
EP3927746A1
(en)
|
2019-02-21 |
2021-12-29 |
Marengo Therapeutics, Inc. |
Multifunctional molecules that bind to calreticulin and uses thereof
|
|
EP4084823A4
(en)
|
2020-01-03 |
2024-05-15 |
Marengo Therapeutics, Inc. |
ANTI-TCR ANTIBODY MOLECULES AND THEIR USES
|
|
WO2021138407A2
(en)
|
2020-01-03 |
2021-07-08 |
Marengo Therapeutics, Inc. |
Multifunctional molecules that bind to cd33 and uses thereof
|
|
CA3180321A1
(en)
|
2020-04-24 |
2021-10-28 |
Marengo Therapeutics, Inc. |
Multifunctional molecules that bind to t cell related cancer cells and uses thereof
|
|
WO2022046920A2
(en)
|
2020-08-26 |
2022-03-03 |
Marengo Therapeutics, Inc. |
Multifunctional molecules that bind to calreticulin and uses thereof
|
|
GB2616128A
(en)
|
2020-08-26 |
2023-08-30 |
Marengo Therapeutics Inc |
Antibody molecules that bind to NKp30 and uses thereof
|
|
JP2023540248A
(ja)
|
2020-08-26 |
2023-09-22 |
マレンゴ・セラピューティクス，インコーポレーテッド |
Ｔｒｂｃ１またはｔｒｂｃ２を検出する方法
|
|
WO2022045865A1
(ko)
|
2020-08-31 |
2022-03-03 |
(주)메디톡스 |
항-ｖｅｇｆ 육량체 항체, 및 이를 포함하는 조성물
|
|
KR20220029343A
(ko)
|
2020-08-31 |
2022-03-08 |
(주)메디톡스 |
항-ｖｅｇｆ 육량체 항체, 및 이를 포함하는 조성물
|
|
KR20240004462A
(ko)
|
2021-04-08 |
2024-01-11 |
마렝고 테라퓨틱스, 인크. |
Tcr에 결합하는 다기능성 분자 및 이의 용도
|
|
CN117255800A
(zh)
*
|
2021-04-28 |
2023-12-19 |
恩格姆生物制药公司 |
具有抗体恒定区变体的结合分子的多聚化
|
|
CN115724985A
(zh)
*
|
2021-08-27 |
2023-03-03 |
三生国健药业（上海）股份有限公司 |
一种cdc平台抗体
|
|
GB202319645D0
(en)
*
|
2023-12-20 |
2024-01-31 |
Kbio Holdings Ltd |
Hexameric protein
|
|
WO2026011013A1
(en)
|
2024-07-02 |
2026-01-08 |
Epibiologics, Inc. |
Binding agents and uses thereof
|
|
WO2026050572A2
(en)
|
2024-08-29 |
2026-03-05 |
Marengo Therapeutics, Inc. |
Multifunctional molecules binding to tcr and uses thereof
|